Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
192 hedge funds and large institutions have $1.28B invested in Intercept Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 70 increasing their positions, 52 reducing their positions, and 29 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 52
28% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 29
2% more funds holding
Funds holding: 188 → 192 (+4)
11% less call options, than puts
Call options by funds: $72.5M | Put options by funds: $81.2M
20% less capital invested
Capital invested by funds: $1.6B → $1.28B (-$320M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$42.5M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$20.8M |
| 3 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$20.2M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.6M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$23M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.8M |
| 3 |
SM
Senvest Management
New York
|
-$16.5M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.92M |
| 5 |
Millennium Management
New York
|
-$8.92M |
ICPT Hedge Fund Activity: Q2 2020 in Review
192 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q2 2020, worth a combined $1.28B — down 20% from $1.6B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new ICPT positions and 29 closed out — a net gain of 8 holders — while 70 added to existing stakes and 52 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $42.5M. The largest seller was Two Sigma Investments, cutting an estimated $23M.
- 192 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q2 2020, up from 188 in Q1 2020.
- Funds reported $1.28B of Intercept Pharmaceuticals, Inc. stock for Q2 2020, down 20% quarter-over-quarter.
- 37 funds opened new Intercept Pharmaceuticals, Inc. positions in Q2 2020 and 29 closed out, a net change of +8 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q2 2020 was Adage Capital Partners, an estimated $42.5M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q2 2020 was Two Sigma Investments, an estimated $23M sold.
Based on aggregated 13F filings for Q2 2020.